Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

计划入组 91 人 · 首次发布于 2019 年 4 月 22 日

IReC-Bio and IReC Registry

计划入组 10,000,000 人 · 首次发布于 2023 年 6 月 2 日

The IRIS-Resolute Integrity (IRIS-Integrity)

计划入组 3,000 人 · 首次发布于 2011 年 7 月 13 日

HDAC inhibitors(Institute for Research in Immunology and Cancer/IRICoR)

RIC

ORIC-533

Iris Sommer

Germany

Hoffman, Eric

United States

Oric Pharmaceuticals

United States

IRIC and Ipsen Initiate Phase 1 Trial of RAF Inhibitor IPN01195 for Solid Tumors

Ipsen Expands Oncology Partnership with Université de Montréal and IRICoR, Adding Two MAP Kinase-Related Discovery Programs

Epitopea's CryptoMap Platform Identifies Novel Immunotherapy Targets in Melanoma and NSCLC